Detail
| LncRNA Name | MIR22HG |
| Synonyms | MIR22HG, C17orf91, MGC14376, DKFZp686O06159 |
| Region | GRCh38_17:1711493-1717174 Sequence |
| Ensembl | ENSG00000186594 |
| RefSeq | NR_028502 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR |
| Sample | hepatocellular carcinoma tissues, cell lines (SMMC-7721, Huh-7 and Hep3B cells) |
| Expression Pattern | down-regulated |
| Function Description | lncRNA MIR22HG expressed significantly lower in HCC tissues compared with non-tumorous tissues. Under-expression of lncRNAMIR22HG was an independent risk factor associated with the prognosis of patients with HCC.under-expression of MIR22HG was closely related to tumor encapsulation, microvascular invasion (MVI), and TNM stage. lncRNA MIR22HG under-expression was an independent risk factor associated with the prognosis of patients with HCC. |
| Pubmed ID | 29371967 |
| Year | 2017 |
| Title | Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy. |
| External Links |
| Links for MIR22HG | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.